NS Healthcare is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
White Paper
March 26, 2024
Randomised controlled clinical trials remain the gold standard in assessing the efficacy of a medical drug, device or intervention. Standardisation in clinical trial design reduces bias, ensures the validity of the trial data, and allows for generalisation of trial results to the larger real-world population who have the disease.
Download to find out more.